Centers for the Investigation of Factor VIII (FVIII) Immune Response in Patients with Hemophilia A (U54) FOA

Opportunity ID: 291601 Opportunity Number: NOT-HL-17-484 Opportunity Title: Centers for the Investigation of Factor VIII (FVIII) Immune Response in Patients with Hemophilia A (U54) FOAOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.837Eligible Applicants: Additional Information on Eligibility: Agency Code: HHS-NIH11Agency Name: Department of Health and Human ServicesNational Institutes of HealthPosted Date: Feb 03, 2017Last Updated Date: Feb 03, 2017Estimated Synopsis Post Date: Apr 01, 2017Fiscal Year: 2018Award Ceiling: Award Floor: Estimated Total Program Funding: Expected Number of Awards: Description: ​The National Heart, Lung, and Blood Institute (NHLBI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) which will support studies that utilize cross-disciplinary science and novel technologies to define the basic mechanisms involved in the development of anti-factor VIII (FVIII) neutralizing antibodies, also known as FVIII inhibitors, in patients with congenital hemophilia A.   This Notice is being provided to allow potential applicants sufficient time to develop responsive proposals.  The FOA is expected to be published in April 2017 with anticipated application receipt dates in July 2017. This FOA will utilize the U54 activity code. Details of the pla...
Source: Grants.gov - Category: Research Tags: Health Source Type: funding